Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Acidaminococcus intestini CAG:325

ABSTRACT: Acidaminococcus intestini CAG:325 overview

PROVIDER: PRJNA207256 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	CBEK01.dat.gz	Other
	CBEK01.fasta.gz	Fasta.gz
	CBEK01.master.dat	Other

Items per page:

1 - 4 of 4

Similar Datasets

Acidaminococcus intestini

Project description:Acidaminococcus intestini overview

| PRJNA37051 | ENA

Acidaminococcus intestini DSM 21505

Project description:Acidaminococcus intestini DSM 21505

| PRJNA188796 | ENA

Commensalibacter intestini

Project description:Commensalibacter intestini overview

| PRJNA73609 | ENA

[Kluyvera] intestini

Project description:[Kluyvera] intestini overview

| PRJNA492574 | ENA

Acidaminococcus fermentans

Project description:Acidaminococcus fermentans overview

| PRJNA37201 | ENA

Disruption of autophagic degradation with ROC-325 antagonizes renal cell carcinoma pathogenesis

Project description:Autophagy plays important roles in malignant pathogenesis and drug resistance. We used medicinal chemistry approaches to generate a series of novel agents that inhibit autophagic degradation. ROC-325 was selected as a lead compound for further evaluation. Comprehensive in vitro and in vivo studies were conducted to evaluate the selectivity, tolerability, and efficacy of ROC-325 in preclinical models of renal cell carcinoma (RCC). ROC-325 exhibited superior in vitro anticancer effects than the existing autophagy inhibitor hydroxychloroquine in 12 different tumor models with diverse genetic backgrounds. Focused studies of the mechanism of action and efficacy of ROC-325 in RCC cells showed that drug treatment induced hallmark characteristics of autophagy inhibition including accumulation of autophagosomes with undegraded cargo, lysosomal deacidification, p62 stabilization, and disruption of autophagic flux. Subsequent experiments showed that ROC-325 antagonized RCC growth and survival in an ATG5/7-dependent manner, induced apoptosis, and exhibited favorable selectivity. Oral administration of ROC-325 to mice bearing 786-0 RCC xenografts was well tolerated, significantly more effective at inhibiting tumor progression than HCQ, and inhibited autophagy in vivo. We used microarrays to determine gene expression changes following 24 h treatment with ROC-325 in RCC cell lines and identified differentially expressed genes.

2018-02-16 | GSE89766 | GEO

Escherichia coli strain:5-325 | isolate:5-325

Project description:Escherichia coli strain:5-325 | isolate:5-325 Genome sequencing

| PRJNA993439 | ENA

Acidaminococcus sp. DS4831

Project description:Acidaminococcus sp. DS4831 Genome sequencing

| PRJNA1102137 | ENA

Sinorhizobium meliloti strain:325

Project description:Sinorhizobium meliloti 325 Resequencing

| PRJNA501527 | ENA

Bradyrhizobium diazoefficiens strain:USDA 325 | isolate:USDA 325

Project description:Bradyrhizobium diazoefficiens USDA 325 genome sequencing